Struys Eduard A, Salomons Gajja S, Achouri Younes, Van Schaftingen Emile, Grosso Salvatore, Craigen William J, Verhoeven Nanda M, Jakobs Cornelis
Metabolic Unit, Department of Clinical Chemistry, VU University Medical Centre, Amsterdam, The Netherlands.
Am J Hum Genet. 2005 Feb;76(2):358-60. doi: 10.1086/427890. Epub 2004 Dec 17.
d-2-hydroxyglutaric aciduria is a neurometabolic disorder with both a mild and a severe phenotype and with unknown etiology. Recently, a novel enzyme, d-2-hydroxyglutarate dehydrogenase, which converts d-2-hydroxyglutarate into 2-ketoglutarate, and its gene were identified. In the genes of two unrelated patients affected with d-2-hydroxyglutaric aciduria, we identified disease-causing mutations. One patient was homozygous for a missense mutation (c.1331T-->C; p.Val444Ala). The other patient was compound heterozygous for a missense mutation (c.440T-->G; p.Ile147Ser) and a splice-site mutation (IVS1-23A-->G) that resulted in a null allele. Overexpression studies in HEK-293 cells of proteins containing the missense mutations showed a marked reduction of d-2-hydroxyglutarate dehydrogenase activity, proving that mutations in the d-2-hydroxyglutarate dehydrogenase gene cause d-2-hydroxyglutaric aciduria.
D-2-羟基戊二酸尿症是一种神经代谢紊乱疾病,具有轻度和重度两种表型,病因不明。最近,一种将D-2-羟基戊二酸转化为2-酮戊二酸的新型酶——D-2-羟基戊二酸脱氢酶及其基因被鉴定出来。在两名患有D-2-羟基戊二酸尿症的无亲缘关系患者的基因中,我们鉴定出了致病突变。一名患者为错义突变(c.1331T→C;p.Val444Ala)的纯合子。另一名患者为错义突变(c.440T→G;p.Ile147Ser)和剪接位点突变(IVS1-23A→G)的复合杂合子,该剪接位点突变导致了一个无效等位基因。对含有错义突变的蛋白质在HEK-293细胞中的过表达研究表明,D-2-羟基戊二酸脱氢酶活性显著降低,证明D-2-羟基戊二酸脱氢酶基因中的突变会导致D-2-羟基戊二酸尿症。